Prospective, Randomized, Double-blind Study of Safety and Tolerability of Intravesical Resiniferatoxin (RTX) in Interstitial Cystitis (IC)

Overview

Journal Int Urogynecol J Pelvic Floor Dysfunct

Specialties Gynecology & Obstetrics
Urology

Date 2005 Apr 9

PMID 15818465

Citations 22

Authors

Tony Y H Chen

Jacques Corcos

Michel Camel

Yves Ponsot

Le Mai Tu

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC) patients.

Materials And Methods: IC patients were instilled with 50 cc of test solution containing either placebo, 0.05 microM or 0.10 microM RTX in the bladder. Plasma concentration of RTX and its degradant resiniferonol 9-, 13-, 14-orthophenylacetate was measured. Immediate post-treatment blood sampling and cystoscopy were performed. Symptoms were evaluated before treatment, at 4- and at 12-week follow-ups, using VAS indicator for pain, voiding diary, and O'Leary's IC symptom/problem indices.

Results: Among 22 patients observed (ten in 0.10 microM RTX, eight in 0.05 microM RTX, and four in placebo groups), the most commonly reported adverse event was pain during instillation (80.0%, 87.5%, and 25.0%). No serious adverse events were reported.

Conclusions: Use of intravesical RTX in IC patients is associated with important tolerability issues but safe at 0.10 microM and 0.05 microM.

Citing Articles

Mechanotransduction in the urothelium: ATP signalling and mechanoreceptors.

Li X, Hu J, Yin P, Liu L, Chen Y Heliyon. 2023; 9(9):e19427.

PMID: 37674847 PMC: 10477517. DOI: 10.1016/j.heliyon.2023.e19427.

Safety and efficacy of intravesical instillation of resiniferatoxin in healthy cats: A preliminary study.

Barletta M, Gordon J, Escobar A, Mitchell K, Trenholme H, Grimes J Front Vet Sci. 2023; 9:922305.

PMID: 36713852 PMC: 9878299. DOI: 10.3389/fvets.2022.922305.

Acute Intravesical Capsaicin for the Study of TRPV1 in the Lower Urinary Tract: Clinical Relevance and Potential for Innovation.

Andersson K, Behr-Roussel D, Denys P, Giuliano F Med Sci (Basel). 2022; 10(3).

PMID: 36135835 PMC: 9504433. DOI: 10.3390/medsci10030050.

Interventions for treating people with symptoms of bladder pain syndrome: a network meta-analysis.

Imamura M, Scott N, Wallace S, Ogah J, Ford A, Dubos Y Cochrane Database Syst Rev. 2020; 7:CD013325.

PMID: 32734597 PMC: 8094454. DOI: 10.1002/14651858.CD013325.pub2.

Regulation of transient receptor potential cation channel subfamily V1 protein synthesis by the phosphoinositide 3-kinase/Akt pathway in colonic hypersensitivity.

Shen S, Al-Thumairy H, Hashmi F, Qiao L Exp Neurol. 2017; 295:104-115.

PMID: 28587873 PMC: 5535076. DOI: 10.1016/j.expneurol.2017.06.007.

References

Maggi C, Santicioli P, Patacchini R, Geppetti P, Giuliani S, Astolfi G . Regional differences in the motor response to capsaicin in the guinea-pig urinary bladder: relative role of pre- and postjunctional factors related to neuropeptide-containing sensory nerves. Neuroscience. 1988; 27(2):675-88. DOI: 10.1016/0306-4522(88)90297-7. View

Winter J, Dray A, Wood J, Yeats J, Bevan S . Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitotoxin. Brain Res. 1990; 520(1-2):131-40. DOI: 10.1016/0006-8993(90)91698-g. View

Szallasi A, Conte B, Goso C, Blumberg P, Manzini S . Vanilloid receptors in the urinary bladder: regional distribution, localization on sensory nerves, and species-related differences. Naunyn Schmiedebergs Arch Pharmacol. 1993; 347(6):624-9. DOI: 10.1007/BF00166945. View

Avelino A, Cruz F, Coimbra A . Intravesical resiniferatoxin desensitizes rat bladder sensory fibres without causing intense noxious excitation. A c-fos study. Eur J Pharmacol. 1999; 378(1):17-22. DOI: 10.1016/s0014-2999(99)00451-3. View

Ishizuka O, Mattiasson A, Andersson K . Urodynamic effects of intravesical resiniferatoxin and capsaicin in conscious rats with and without outflow obstruction. J Urol. 1995; 154(2 Pt 1):611-6. DOI: 10.1097/00005392-199508000-00080. View

Lazzeri M, Beneforti P, Spinelli M, ZANOLLO A, Barbagli G, Turini D . Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study. J Urol. 2000; 164(3 Pt 1):676-9. DOI: 10.1097/00005392-200009010-00014. View

Szallasi A . Vanilloid (capsaicin) receptors in health and disease. Am J Clin Pathol. 2002; 118(1):110-21. DOI: 10.1309/7AYY-VVH1-GQT5-J4R2. View

Chancellor M, de Groat W . Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol. 1999; 162(1):3-11. DOI: 10.1097/00005392-199907000-00002. View

Erickson D, Belchis D, Dabbs D . Inflammatory cell types and clinical features of interstitial cystitis. J Urol. 1997; 158(3 Pt 1):790-3. DOI: 10.1097/00005392-199709000-00025. View

10.

Amann R . Desensitization of capsaicin-evoked neuropeptide release--influence of Ca2+ and temperature. Naunyn Schmiedebergs Arch Pharmacol. 1990; 342(6):671-6. DOI: 10.1007/BF00175711. View

11.

Cruz F . Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders. Int Urogynecol J Pelvic Floor Dysfunct. 1998; 9(4):214-20. DOI: 10.1007/BF01901607. View

12.

de Seze M, Wiart L, Joseph P, Dosque J, Mazaux J, Barat M . Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn. 1998; 17(5):513-23. DOI: 10.1002/(sici)1520-6777(1998)17:5<513::aid-nau7>3.0.co;2-g. View

13.

Silva C, Rio M, Cruz F . Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia. Eur Urol. 2000; 38(4):444-52. DOI: 10.1159/000020322. View

14.

Craft R, Cohen S, Porreca F . Long-lasting desensitization of bladder afferents following intravesical resiniferatoxin and capsaicin in the rat. Pain. 1995; 61(2):317-323. DOI: 10.1016/0304-3959(94)00193-I. View

15.

Lazzeri M, Spinelli M, Beneforti P, ZANOLLO A, Turini D . Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases. Scand J Urol Nephrol. 1998; 32(5):331-4. DOI: 10.1080/003655998750015287. View

16.

Szallasi A, Blumberg P . Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev. 1999; 51(2):159-212. View

17.

Giannantoni A, Stasi S, Stephen R, Navarra P, Scivoletto G, Mearini E . Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. J Urol. 2002; 167(4):1710-4. View

18.

Blok B . Central pathways controlling micturition and urinary continence. Urology. 2002; 59(5 Suppl 1):13-7. DOI: 10.1016/s0090-4295(01)01633-8. View

19.

Dodd L, Tello J . Cytologic examination of urine from patients with interstitial cystitis. Acta Cytol. 1998; 42(4):923-7. DOI: 10.1159/000331969. View

20.

Silva C, Avelino A, Souto-Moura C, Cruz F . A light- and electron-microscopic histopathological study of human bladder mucosa after intravesical resiniferatoxin application. BJU Int. 2001; 88(4):355-60. DOI: 10.1046/j.1464-410x.2001.02339.x. View